RDInvesting Provides Investors with Free In-Depth Equity Reports on ASML, BIIB, GRMN and MT
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
ASML Holding N.V. (NASDAQ: ASML) shares declined 0.69 percent to close at $81.53 a share Monday. The stock traded between $81.35 and $83.25 on volume of 1.40 million shares traded. Deutsche Bank has recently upgraded the company’s rating to “buy” from “hold”. Shares of ASML have gained approximately 26.5 percent year-to-date.
Find out more about ASML including full access to the free equity report at:
www.RDInvesting.com/ASML
Biogen Idec Inc. (NASDAQ: BIIB) shares declined 1.62 percent to close at $218.07 a share Monday. The stock traded between $217.50 and $225.22 on volume of 943,600 shares traded. Citigroup has recently upgraded the company’s rating to “buy” from “neutral”. Shares of Biogen Idec have gained approximately 49.0 percent year-to-date.
Find out more about Biogen Idec including full access to the free equity report at:
www.RDInvesting.com/BIIB
Garmin Ltd. (NASDAQ: GRMN) shares declined 1.08 percent to close at $34.96 a share Monday. The stock traded in between $34.93 and $35.67 on volume of 723,077 shares traded. Thomson Reuters/Verus has recently upgraded the company’s rating to “buy” from “hold”. Shares of Garmin are down approximately 14.2 percent year-to-date.
Find out more about Garmin including full access to the free equity report at:
www.RDInvesting.com/GRMN
ArcelorMittal (NYSE: MT) shares gained 1.16 percent to close at $11.32 a share Monday. The stock traded in between $11.28 and $11.40 on volume 3.40 million shares traded. Nomura has recently upgraded the company’s rating to “buy” from “neutral”. Shares of ArcelorMittal have fallen approximately 35.0 percent year-to-date.
Find out more about ArcelorMittal including full access to the free equity report at:
www.RDInvesting.com/MT
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com